Sources Sought - Blood Donor Testing Services (Fort Bliss, Texas)
Closed Pre-Solicitation Posted
- Solicitation number
- PANHCA25P0000_007533
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- Fort Bliss, Texas 79918, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of the Army Medical Command is conducting market research for blood donor testing services at Fort Bliss, Texas, through a sources sought notice. The procurement will support William Beaumont Army Medical Center and requires a comprehensive blood donor testing capability that includes standard panel tests for various diseases and conditions such as HIV, hepatitis, syphilis, West Nile Virus, and Zika. Interested companies must submit a five-page capability statement by March 29, 2025, at 11:59 PM Central Time, demonstrating their ability to perform complex medical laboratory testing. Evaluation criteria will focus on the respondent's capability to provide the specified testing services, capacity to manage a contract of this magnitude, and their current business status. All respondents must be registered in the System for Award Management (SAM.gov) and can submit their responses via email to specific government points of contact.
The procurement is classified under NAICS code 621511 for Medical Laboratories, with a small business size standard of $41.5 million. The anticipated contract structure includes a one-year base period with four potential one-year option periods, using a firm fixed-price model. The annual testing volume is estimated at 6,500 standard donor panel tests, with additional specific tests for T. Cruzi and Babesia. There is no specific small business set-aside for this opportunity, and all testing must be executed at the contractor's facility or within their laboratory network, in strict compliance with FDA regulations. While no specific award value is mentioned, the comprehensive testing requirements and multi-year potential suggest a significant contract opportunity for qualified medical laboratory service providers.
Notice text
ABOUT
Medical Readiness Contract Office - West, is currently performing market research for an upcoming requirement in support of William Beaumont Army Medical Center, Fort Bliss, TX. The type of solicitation to be issued will be based upon replies to this sources sought, in addition to other market research performed. It is anticipated that a firm fixed-priced contract will be awarded to fulfill this requirement. Please note that this is a sources sought notice for the purposes of market research and to be used for preliminary planning purposes. This is not a solicitation for proposals and no contract will be awarded from this notice.
Contact with Government Personnel, other than the points of contact identified at the bottom of this notice, by any potential firm, or their employees’, regarding this requirement is strictly prohibited.
The North American Classification System (NAICS) code for this requirement is 621511 – “Medical Laboratories.” The Small Business Size Standard is $41.5 Million.
SCOPE
- Provide all required facilities, personnel, services, transportation (i.e.,shipping) , materials, equipment, and supplies required to provide blood donor testing services in support of the U.S. Government. It is anticipated that the period of performance will include a one-year base period and four, one-year, option periods.
- All tests shall be executed at the Contractor's facility, or within the Contractor's network of laboratories (affiliate or qualified sub-contractor).
- All testing shall be in accordance with the Food and Drug Administration (FDA) regulations.
- The standard test panel includes:
- ABO/Rh Antibody screen
- Syphilis (STS)
- HBsAg
- HBcAb
- HCV
- HIV 1 and 2
- HTLV I/II
- HIV/HCV/HBV NAT (pooled)
- West Nile Virus NAT IDT (single)
- Chagas (T.cruzi)
- Babesia (pooled)
- and Zika (single).
The confirmatory testing will consist of individually run tests:
- HBsAg Neutralization
- HCV confirmatory
- HBV confirmatory
- HIV 1 and HIV 2 confirmatory
- HTLV I/II confirmatory
- Syphilis (TP-PA) confirmatory,
- discriminatory NAT for HIV,
- HCV and HBV and Chagas.
Notes:
- HLA (Human Leukocyte Antigen) and anti-A, anti-B Antibody Titer will not be performed on every donor or potential donor but must be available upon request.
- The annual volume is estimated at 6,500 standard donor panel tests, per year, along with 6,500 tests each for T. Cruzi and Babesia.
RESPONSES
Responses to this Sources Sought Notice should demonstrate the company’s capability and responsibility to provide and deliver the products listed below. A response to this sources sought notice will be interpreted as confirmation that the respondent is interested and will likely provide a proposal/quote in response to a solicitation when issued. If your company is unlikely to respond to a solicitation but is providing information for future use, please indicate such.
In response to this notice, interested parties must submit a written capability statement (please limit to 5 pages) and include the following information:
- Company name, address, point of contact, phone number, and e-mail address.
- Indication of the company’s capability to provide the products/services being requested; please indicate if Company will perform tests or subcontract for the performance of testing.
- Documentation of company’s capability to perform under contract of this magnitude and complexity; historical or current awards may be specified, if desired.
- Small Business or Large Business Status along with UEI or CAGE code for review in SAM.gov.
Interested parties shall respond to this Sources Sought Notice no later than 28 March 2025 at 11:59 PM Central Time. All interested businesses must be registered in the System for Award Management (SAM) at www.sam.gov to be eligible for award of Government contracts. Email your response to Christopher A. Gregory at email: christopher.a.gregory11.civ@health.mil or robyn.a.villafranco.civ@health.mil. Telephonic inquiries will not be honored.
Notice: Respondents are responsible for marking information that is proprietary in nature. No reimbursement will be made for any costs associated with providing information in response to this notice or any follow up information requests. The Government is not obligated to, nor will it, pay for or reimburse any costs associated with responding to this sources sought notice. This notice shall not be construed as a commitment by the Government to issue a solicitation or ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. The Government will in no way be bound to this information if any solicitation is issued. No subcontracting opportunity is anticipated. A determination by the Government to not compete this proposed contract action based on the responses to this notice is solely within the discretion of the Government.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Integrated Multi-Modality Transfusion-Transmitted Disease (TTD) Testing Systems for Armed Services Blood Bank Center-Europe (ASBBC-EUR), Landstuhl Regional Medical Center (LRMC), Germany | Defense Health Agency | No set-aside | |
| 6505--Human Blood and Blood Products | Veterans Integrated Service Network 17 | No set-aside | |
| BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systems | Defense Health Agency | Service-Disabled Veteran-Owned Small Business | |
| 6640--karius test | Veterans Integrated Service Network 8 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity